Athyrium Capital Management And Esperion Therapeutics Enter $50M Royalty Financing Agreement On Japanese Sales Of Bempedoic Acid Products
Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. ESPR | 0.00 |
Athyrium Capital Management And Esperion Therapeutics Enter $50M Royalty Financing Agreement On Japanese Sales Of Bempedoic Acid Products
